ArticleOncoTargets and therapy2020

Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway.

Huixue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.